<i>DUX4</i> expression is a significant predictor of survival even after accounting for tumor mutational burden and other molecular and clinical features in this cohort, with <i>DUX4</i> expression associated with a median reduction in survival of over one year. Here, DUX4 is linked to neoplasm.